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had a peculiar odor. Her efforts to get help for her children and to learn the 
cause of this odor (the odor is present when phenylacetic acid is secreted in the 
perspiration and urine of persons with PKU; the distinctive odor of this compound 
is described as 11musty", "horsy", or "barnlike".) led her from doctor to doctor 
over a period of years. Finally she interested a Norwegian physician and bio-
chemist, Dr. Ashborn Falling. 
In the process of examining the children, Dr. F~lling discovered that the 
urines of both reacted with ferric chloride to give an unuaual, green color. This 
he proved was due to the presence of phenylpyruvic acid, which he was able to cry-
stallize in pure form from the urine samples. The same simple ferric chloride urine 
test and modifications thereof and newer simplified blood test such as that developed 
by Robert Guthrie make early diagnosis of PKU possible today. 
(Note: The designation "phenylketonuria" or "PKU" refrers to the urinary 
excretion of phenylpyruvic acid.) 
As newtof this newly discovered disease spread, patients in institutions for 
the mentally retarded in many countries were similarly tested. Out of such studies 
came figures for incidence, determinations of type of inheritance, and a fairly 
complete clinical picture of the disease. Study of these patients also provided 
information by which much of the metabolic error eventually was mapped out. Be-
cause phenylpyruvic acid, the substance responsible for the green color reaction 
with ferric chloride in the urine, is a phenylketone, the name phenylketonuria, 
or PKU, was suggested for this disease. To date, this is the name of preference 
although other names have been suggested. 
It was soon discovered that PKU is found on the average in one-half of 1 
percent to 1 percent of institutionalized mental defectives. Interpolating from 
this prevalence, it was estimated that PKU occurs once in every 20,000 to 40,000 
iive births. A comparison ~f birth statistics and causes of PKU discovered over 
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a 10-year period in Utah suggested that the incidence must be somewhat more than 
1 in 20,000, Extensive mass testing of blood phenylalanine levels of newborns in the 
United States suggests that the incidence is in the neighborhood of 1 in 10,000 live 
births. Sexes are essentially equally affected and all races appear to be involved, 
However, the incidence is relatively higher in people of European stock and is 
particularly low in people of Askenazi Jewish and Negro ancestry. It has been reported 
from India (hindu and Muslim) and from the Orient (Japan and China). 
Because PKU often involves more than one child in a family, it was recognized 
from the beginning as a familial disorder. When it was determined that the parents 
were normal and that approximately 1 in 4 children in the involved families had 
PKU, it was concluded that PKU was inherited by a simple, autosomal, recessive gene. 
The following diagram represents the mode of inheritance in a classical PKU family. 
normu I urriers phenylketonuria 
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In this situation the normal parents are each carriers (Pp) of the defective 
gene for PKU. The children from two such parents can be noncarriers (PP) or carriers 
like the parents (Pp), or have two abnormal genes (pp) and have phenylketonuria (PKU). 
Thus each pregnancy of such parents has a 1 in 4 chance of resulting in a PKU child (pp) 
and a 3 in 4 chance of resulting in a phenotypically normal child (PP and Pp). 
If we assume that the incidence of PKU in the general population is 1 in 10,000 
then it can be determined that 1 in 50 of the general population is a carrier of this 
disease. (This figure is derived by multiplying 1:10,000 by 4 and then taking the 
square root.) To better understand this figure, one can calculate in reverse that 
the chance of two such carriers in the general population marrying each other would 
be 1/50 x 1/50 or once in 2,500 marriages. If each of these 2,500 couples, including 
the "carrier" couple, had four children, then one of the 10,000 offspring would be 
expected to have PKU. Since PKU is transmitted by inheritance of an autosomal, 
recessive gene, homozygous phenylketonurics rarely mate. As more widespread 
success in the dietary management of this genetic disorder is achieved, however, 
the incidence of marriage by mentally normal adults with phenylketonuria will increase. 
All children of such a union will be phenylketonuric. 
It should be realized that the exact incidence of PKU and thus the incidence 
of carriers is as yet unknown. This fact will not be ·determined until there are 
more wide scale screening programs of the general population and more extensive 
use is made of improved methods for "carrier" detection. Earlier proposed means 
of determining "carriers, 11 although useful, have some limitations in clinical 
application--mainly because of overlap between normal and "carrier" results. 
Newer approaches have not successfully reduced discrimination below 4 percent. 
Phenylketonuria is known as an inborn error of metabolism. The basic defect 
caused by the PKU gene is lack of the enzyme phenylalanine hydroxylase which normally 
changes the essential amino acid phenylalanine to tyrosine. If PKU is permitted to 
progress, brain development is arrested and severe mental deficiency results. 
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If the mother has essentially normal metabolism, the baby seems to be 
protected before birth. As soon as a newborn baby with PKU begins to take milk 
(breast milk or cow's milk), phenylalanine, which constitutes approximately 5 
percent of all proteins, is absorbed. Blocked in its normal metabolic pathway, 
the phenylalanine builds up to serum levels of about 20 times the normal. This 
takes place fairly rapidly. By the time the infant is 1 to 6 weeks of age, abnormal 
byproducts of this high serum phenylalanine begin to appear in the urine. It is 
believed that the continued high level of phenylalanine or its related metabolites is 
responsible directly or indirectly for the mental retardation. This view is amply 
confirmed by the fact that low phenylalanine diets started on PKU infants in the 
early months of life (so that serum phenylalanine levels remain within the normal 
or near-normal range), have resulted in normal mental development. (If a newborn 
PKU infant doesn't receive milk (proteins) the serum phenylalanine level still will 
show some rise within a few days due to catabolism of body proteins.) 
Although the mechanism of the adverse effect of elevated levels of phenylalanine 
or abnormal metabolites of phenylalanine metabolism has not been clarified, some 
facts are beginning to emerge. There is experimental evidence of an inhibitory 
effect on enzyme systems active in significant metabolic and transport processes. 
It is known that there is a significant inhibition of serotonin products in untreated 
patients with PKU which can be normalized under therapeutic dietary control. Also, 
there is evidence of failure of myelination or loss of myelin in about a third of 
PKU patients examined histologically. A rare case of PKU now and then is reported 
to have developed normal mentality without any treatment. Still many questions 
remain yet unanswered about the mechanism of the adverse effect in PKU. 
The untreated PKU patient is born apparently normal but begins to show 
retardation early in life. At about 3 or 4 months of age, a subtle change may 
be noticed, The infant begins to lose interest in his surroundings, and thereafter 
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development is slowed down or arrested until by 2 or 3 years of age most are in the 
below "50 I,Q," range of mental deficiency. Of the known untreated cases in institu-
tions, 90 percent fall into this bracket, Occasional untreated cases (perhaps 10 
percent) are only mildly retarded and a few cases (less than one-half percent) have 
been reported with normal mentality. 
PKU children usually are fairly well developed physically and have no truly 
diagnostic stigmata other than the characteristic musty odor. Older children may 
exhibit slight stunting of height and some have smaller than average head sizes. 
Patients with PKU may have blue eyes, blonde hair, and fair skin when compared to 
their parents and normal siblings. Although there are many exceptions, approxi-
mately 80 percent are blonder than their parents and normal siblings. 
The average age cJ untreated PKU children for sitting alone is from 12 to 15 
months; the average age for walking is 2~ years, for talking 3~ years. Some never 
learn to walk; many nver learn to talk. Behavior patterns are frequently autistic, 
hyperirritable, and destructive. About 80 percent have abnormal EEG 1 s (electro-
enecphalographs) and approximately 25 percent have convulsions. (Convulsions are 
uncommon after 10 years of age.) The more severely involved cases may show signs of 
upper motor neuron damage such as positive Babinski and ankle clonus. About 25 
percent of PKU patients have eczema, which is pruritic and not limited to any 
specific areas of the body and which may have its onset within the first few months 
of life. Although not reversible, this process can be arrested by proper dietary 
management. Clinical signs such as vomiting, eczema, and urine should be stressed. 
There are two basic types of programs in use for the screening of babies .• 
Historically, the first of these was one of the ferric-salt urine tests performed 
on babies between 1 and 2 months of age, at the time when phenylpyruvic acid 
ordinarily appears in the urine of an affected child. When using the urine test it 
is best to repeat this test three times on each child at each of the first three 
A classical setting for PKU: The one child in four involved with PKU is severely 
mentally retarded, has a disturbed behavior pattern, had a history of convulsioru 
earlier in life, and is blonder than his parents and normal brother and sisters. 
Phenylalanine tolerance studies revealed that the parents and two of the three 




In the United States, where the majority of babies are born in hospitals, 
the Guthrie inhibition assay blood test is recommended on the third day of life. 
This test is simple, inexpensive, and can be performed in large numbers. Public 
health departments in many states have been setting the example through pioneering 
such screening programs for PKU. Followup blood testing by this method is recommended 
at 1-2 months of age. If two successive serum phenylalanine levels are normal, PKU 
can be safely ruled out. 
The inhibition assay blood test can be performed on specimens collected simply 
by placing a drop of blood dried on a piece of filter paper. It is known that in a 
phenylketonuric baby the blood level of phenylalanine rises rapidly after birth, and 
blook taken on the third day of life will usually reveal the disease. The great 
advantage of this type of test is the possibility of systematically testing practically 
all babies. Extensive screening trials using this method on newborn babies in the 
United States have resulted in detection o~ cases at a twofold to fourfold higher 
incidence than the previously estimated frequency for PKU, which has been 1:20,000 
to 1:40,000. 
The screening of mentally retarded populations for PKU has been done for many 
years in a good number of institutions for the retarded, whereas in many others such 
detection efforts are more recent. Although it is unlikely that the intelligence 
of children picked up by this method can be improved very much by dietary control, 
diagnosing older children is such an important way to protect subsequent siblings 
and other related infants with PKU that routine screening for the retarded, in all 
institutions, schools, or classes, both public and private is strongly recommended. 
The success of such programs will depend on many cooperating organizations. 
Case finding will have to be followed systematically into the homes of the families 
in a way somewhat similar to screening families in which an active case of tuberculosis 
has been found. 
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A home survey of the siblings of 20 PKU patients at an institution of 
3,000 population uncovered three previously undiagnosed cases. Two of these 
were still young enough to receive benefit from treatment. On the basis of this 
experience, several recommendations have been made for followup work with families 
of PKU patients: 
1. The families should be carefully oriented and counseled as soon 
as possible. The orientation should also include an explanatory 
letter or literature that describes the problem. The information 
should also be forwarded to the family physician. Information 
pamphlets for parents are now available. 
2. All siblings should be screened as soon as possible, even if the 
parents do not think they are retarded. Sometimes retardation in 
young children is unsuspected by the parents. 
3. All newborn siblings should have serum phenylalanine determinations 
just prior to discharge from the newborn nurseries (at 3 or more 
days of age). If this is not possible, they should have urine tests 
at 2, 4, 6, 8, and 12 weeks of age. As an extra precaution, it is 
advisable to do similar followup urine tests, even on newborn sib-
lings who have had a normal serum level. 
4. The families should be encouraged to notify other relatives so that 
young cousins, second cousins, nieces, and nephews can be tested for 
PKU during early infancy. 
Because of the sometimes associated findings of behavior disturbances, con-
vulsions, cerebral palsy, and eczema in PKU patients, it is advisable to screen 
children presenting such problems in clinics, medical centers, or in private 
practice, including those with or without mental retardation. In addition, mothers 
of retarded children should be screened. Maternal PKU has been reported as a cause 
of mental retardation in non-PKU offspring, due to the damaging effect to the foetus 
before birth caused by the mother's high phenylalanine blood levels. 
Now we shall examine the different types of tests used in detection of PKU. 
There are two broad categories of tests--blood tests and urine tests. First, 
let's look at the blood tests for phenylalanine. 
Screening test. This test which was developed by Guthrie is called the 
inhibition assay method of determining phenylalanine in the blood. Only a small 
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amount of blood is needed, which can be obtained easily by heel puncture and collected 
on a filt~r pap~r. The test is based on the fact that the inhibition of the growth 
of Bacillus subtilis by beta-2-thienylalanine is prevented by phenylalanine, 
phenylpyruvic acid, and phenyllactic acid, With cautious training of technicians 
to impose judicious control of procedures the incidence of false positives can 
be held to a practical level, Some workers have reported excellent results with 
the use of the Guthrie method for diet regulation. The method, however, is subject 
to a greater chance for error in carrier studies than the biochemical methods which 
measure only phenylalanine rise after an oral load. 
Earlier methods of determining serum phenylalanine required from 2 to 5 cc. 
of blood and thus were not suitable for screening small babies. The Guthrie pro-
cedure is a simple and inexpensive test and can be performed in large volume. The 
blood-saturated filter paper can be sent through the mails for analysis in a central-
ized laboratory. A blood-saturated filter paper can remain at room temperature for 
several days without significantly affecting the test results, (See following pages 
for examples.) 
Confirmatory tests, Quantitative serum phenylalanine determinations are 
used for final confirmation of the diagnosis of PKU in cases seemingly positive 
by urine tests and the inhibition assay blood test, and for clinical care. Also 
it might be advisable to determine the serum phenylalanine level on a child who 
seems to suggest strongly the diagnosis of PKU but whose urine tests are negative; 
there are instances of PKU in which serum phenylalanine levels, although definitely 
elevated above normal, are just at the renal threshold level so that excretion 
of metabolites into the urine is inconsistent. No infant or child should be 
started on the long-term program of a low-phenylalanine diet without blood-test 
confirmation of the disease . The serum specimen (2 cc,) can be safe l y stored in 
BLOOD SCREENING FOR PHENYLKETONURIA 
Robert Guthrie and Ada Susi 
1. After puncture the baby's 
heel is touched to the filter paper. 
The specimens are then malled to the 
lab. 
2. After autoclaving, a small 
disk is punched out of each blood spot. 
3. The melted agar culture medium, containing the phenylalanine antag-
onist fJ-2-thienylalanine, is inoculated with Bacillus subti!'ls spores, poured into 
flat dishes and allowed to solidify. 
4. The blood paper disks frolll as many as 100 patients are, in addition 
to 8 co-ntrol disks, placed upon the agar surface in rows, and after overnight 
Incubation, the results are observed. 
5. An indication of PKU is a blood disk producirlg a growth halo corre-
sponding to any of the 4 highest control disks. This indication is then confirmed 
by a quantitative blood determination. The control disks are prepared from 
blood containing phenylalanine in the following concentrations: 2,4,4,6,6,8,12 and 
20 milligram per l,OO mi. 
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Date first milk feeding -----------------
Bottle D Breast 0 Both 0 
Date of birth---------------------
FILL ALL CIRCLES WITH BLOOD 
0 0 0 
Filter paper used for collecting specimen from heel puncture. 
Blank space in center is for hospital's identification on specimen. 
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HOSPITAL PKU BLOOD TEST 





Bottle 0; Breost 0; Both 0 





!.!..'J.. 3 CIRCLES WITH BlOOD 
(Be sure blood soaks through.) 
000 
This part mailed in by the hospital. 
000 4 WEEKS PKU BLOOD TEST 
DOCTOR !!ill., J CIRClES WITH BLOOD - .111JUL 







This part torn off for the mother 
to give to the baby's doctor for use 




a freezer and tested later if an immediate serum phenylalanine determination is 
unavailable. In this way there need be no long delay in initiating dietary 
treatment because of local lack of certain laboratory facilities. 
There are other indications as well for the use of the serum phenylalanine 
level. Subsequent siblings born into a family where PKU is present in an older 
child have a 25 percent chance of also having PKU. Cord levels of newborn infants 
with this disorder are not sufficiently elevated to establish the diagnosos. Cord 
levels are somewhat higher than maternal levels. By 2 or 3 days postnatally, how-
ever, the serum phenylalanine has risen to abnormally high levels (10 to 15 mg.); 
a blood specimen at this time usually is adequate to make the diagnosis except 
in the premature. In the latter, caution must be exercised because of immature 
enzyme systems causing temporary elevations of serum phenylalanine. It takes a 
week or longer (rarely up to six weeks) before phenylpruvic acid can be detected 
in the urine. Thus, newborn siblings of known PKU children should be fed a milk 
formula until blood specimens are obtained on the third or fourth day of life. 
Serum phenylalanine determinations are now sufficiently simple and in such wide-
spread use that there should be little delay in clarification of the zygosity of 
the infant. If for some reason clarification is delayed, the infant may be tempor-
arily placed on a low-phenylalanine diet. Then, if the serum value is elevated 
the diet is continued; if normal, a regular diet is initiated. 
The PKU infant or child on a low-phenylalanine diet should have periodic 
determinations of his or her serum phenylalanine levels. Several methods for 
determining serum phenylalanine levels are quantitatively sensitive enough for 
this purpose and for research and other investigative efforts such as phenylalanine 
tolerance tests for detection of carriers of the PKU gene. 
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The various methods fro determining serum phenylalanines are too comples 
for description in this brief report. Many medical school centers and some re-
search centers and commercial laboratories are able to do these determinations. 
Urine tests for phenylpyruvic acid. Several urine tests and modifications 
of urine tests are available for the identification of PKU. A study was done at 
the College of Medical Evangelists School of Medicine, Los Angeles, California, 
(now the Lorna Linda University School of Medicine) to try to determine the advan-
tages or disadvantages of the various urine tests for screening purposes. In this 
study several thousand evaluations were made on 132 consecutive urine samples taken 
from 20 untreated institutionalized cases of PKU. The effects of many factors on 
the urine tests were measured, such as pH, specific gravity, turbidity, a.m. and 
p.m .. voiding, age and sex of patients, hours of standing after voiding, etc. 
The most important variable which affected all the tests was the freshness 
of the urine sample. Unless the urine has been frozen or a preservative added, 
it should be freshly voided for accurate results. Although deterioration is less 
rapid when the urine is dried on filter paper, 10 percent will no longer test 
positive after 3 days. Factors such as cost of the test and ease of administration 
were also compared. All the tests studied were comparable in accuracy, and each 
had enough specific merits to make that test valuable under certain circumstances. 
It was found that in each of these tests the value is dependent on some 
simple but specific precautions which if not understood and appreciated can easily 
cut the efficiency of that test considerably. On rare occasions PKU patients fail 
to excrete phenylpyruvic acid; therefore, the possibility of this disease can not 
be excluded on the basis of one negative urine test. Because the diagnosis is of 
great concern to the family and involves an expensive, long-term treatment, all 
positive urine tests should be confirmed with a serum phenylalanine level before 
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the diagnosis of PKU is established and treatment begun. In a rare circumstance, 
when a serum phenylalanine level can not be obtained within a week, treatment 
may be started on a presumptive diagnosis of two confirmatory urine tests, for 
example, ferric chloride and dinitrophenylhydrazine. In such a case, however, 
a sample of pretreatment serum should be frozen for later phenylalanine deter-
mination. 
Ferric salt tests. The test-tube test with ferric chloride is the oldest, 
best known, most widely used of any of the urine tests for PKU and it is the 
only one I will attempt to cover in my report. The color reaction of ferric 
chloride with phenylpyruvic acid is practically pathognomonic. Immediately 
there is a medium-dark, blue-green to gray-green color which fades in a matter 
of seconds, or minutes, depending upon the concentration of the phenylpyruvic 
acid in the urine and the strength of the ferric chloride solution being used. 
This fading of the color back to a neutral or negative urine color is most 
useful in differentiating the true phenylpyruvic acid reaction from most so-
called false-positive reactions. Ingested salicylates, for example, will give 
the urine a blue-purple color upon application of ferric chloride. Unlike the 
phenylpyruvic acid reaction, however, this color does not fade away. Some of 
the color responses obtained when a ferric chloride solution is added to urine 
samples are: green from bile, homogentisic acid (alcaptonuria), the catecholamines 
(pheochromocytoma), and the urine of maple syrup disease, red brown from diacetic 
acid, gray from melanin, light violet from chlorpromazine ingestion, and purple 
from proclorperazine ingestion. Color reactions are fairly stable except with 
homogentisic acid. In this case the green color is extremely fleeting, disap-
pearing within a second or two. The fact that the ferric chloride reagent will 
demonstrate the presence of various drugs and unusual metabolites other that 
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phenylpyruvic acid does not impair the values of this test but rather makes it 
more interesting and more valuable. For example, the first cases of histidinemia 
were discovered by finding individuals with positive ferric chloried urine test 
but normal serum phenylalanine content. 
The ferric chloride solution is very inexpensive and when made with distilled 
water and stored in polyethylene bottles it is stable indefinitely. A 10 percent 
solution is preferred because of its quick, intense color reaction. When a few 
drops are added to a small amount (1 cc.) of urine, it has been found unnecessary 
to add acid first because the ferric chloride solution is itself very acid. 
The diaper test is a modification of the ferric chloride test-tube test. 
A drop of 10 percent ferric chloride is placed on a baby's wet diaper (or even 
if the diaper has dried since being wet), and a blue-green to gray-green color 
appears immediately. The concomitant use of a drop of acid is neither necessary 
nor desirable. As with the test-tube test, the color is transient. Many times 
a definitely ~ositive test will fade in less than half a minute. Such fading 
starts in the center of the spot, and the last to fade is the green-rimmed 
periphery. Whether positive or negative, the spot on the diaper leaves a 
permanent stain. This is perhaps worth mentioning to the mother. Although 
thousands of infants have been tested there has been no real complaints from 
the mothers. 
The same false-positive reactions occur with the diaper test as with the 
test-tube test. The test has proved to be inexpensive and simple to perform. 
One penny's worth of solution can test several hundred infants. Of 104 PKU 
urine specimens allowed to stand at room temperature for 4 hours, 97 (or 93 
percent) still definitely tested positive with ferric chloride. 
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In practice it was found that in a considerable number of cases the 
infant did not have a wet diaper, and the mother had no wet diaper with her. 
For this reason, mothers are instructed to bring along with them on the initial 
and subsequent clinic visits the most recently wet diaper. In this way approx-
imately 30 percent additional infants may be tested who would otherwise be missed. 
False-negative tests unfortunately do occur and this test is not as reliable as 
the ferric chloride test-tube test. 
The dinitrophenylhdrazine test-tube test, Properly prepared and used, the 
dinitrophenylhydrazine (DNPH) reagent is the most sensitive and reliable of the 
various urine tests for PKU. False-negative test reactions using DNPH on known 
untreated cases of PKU are rare (less than 1 percent). Because other substances 
rarely found in urine will react to give a positive test with the DNPH, any 
positive test should be cross-checked with a ferric chloride test. 
Dietary treatment for PKU was first described in the early 1950's and 
has since been reported in enough cases to establish its efficacy in the 
treatment of infants and small children, When the diet has been started in 
the first several months of life, significant mental deficiency is thoug~to 
be prevented. The rate and irreversibility of the deterioration are somewhat 
variable; however, it is generally felt that the diet should be tried on all 
children under 3 years of age and that many of these may be significantly im-
proved. The cases of children above 3 years of age have to be considered indi-
vidually. It is felt by some workers in this field that older PKU children who 
are only mildly retarded or who have marked behavioral or convulsive disorders 
are more likely to show benefit from diet management than others in the same age 
group. 
The purpose of the diet is to lower the blood phenylalanine from the abnor-
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mally high levels caused by the disease (15-60 mg. per 100 ml. of serum) to 
near normal levels (1-3 mg.) while promoting normal body growth by the provision 
of all essentials for good nutrition, Because all proteins in normally available 
foods are 4 to 6 percent phenylalanine, it is impossible to devise a diet from 
such foods that will lower the phenylalanine level and still provide sufficient 
protein for growth and repair. Therefore, all low phenylalaning diets are based 
on synthetic foods with provide amino acids with little phenylalanine. Most of 
these synthetic foods have been made with a modified casein hydrolysate. Several 
products have been available commercially in the United States and Europe. Actually, 
these special products are so low in phenylalanine that if given by themselves they 
would produce a phenylalanine deficiency, including poor growth and a paradoxical 
rise in serum phenylalanine due to catabolism of body protein. Phenylalanine is 
an essential amino acid and the body requires a certain minimal daily amount. An 
opportunity is thus provided for varying the diet by the addition of low protein 
vegetables and fruits--with the goal of maintaining a serum level of from 2 to 6 
mg. of phenylalanine per 100 ml. of serum. (These are believed to be the safe 
levels. How high the phenylalanine can be kept and still get the best results 
has not been determined.) The serum level of phenylalanine at which phenylpyruvic 
acid will begin to appear in the urine is between 10 and 15 mg. per 100 ml. Urine 
tests are inadequate as checks of dietary control. There is need of periodic serum 
phenylalanine level determinations. It is advised that these serum levels be ob-
tained at intervals not less than every 2 to 4 months while a child is on the low-
phenylalanine diet, (And tests should be run even more frequently during the early 
months of control.) The serum levels are necessary to detect both excesses and 
deficiencies of phenylalanine so the diet can be adjusted accordingly. 
In the United States experience has largely been with an American-made product, 
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Lofenalac@. Lofenalac8 has fat, carbohydrate, and certain minerals and vitamins 
incorporated with the low-phenylalanine casein hydrolysate. One measure (table-
spoon) of LofenalaJ' powder has approximately 1~ gm. of protein equivalent, with 
7~ mg. of phenylalanine. One measure (tablespoon) added to 2 ounces of water 
makes a 20 calorie to the ounce formula which has almost the same consistency, 
appearance, and components as milk minus 90 percent of its phenylalanine. It 
has a nutlike flavor which has been well accepted by almost all patients. Most 
of the children have taken it as a beverage either standard strength or somewhat 
concentrated. Several have preferred to take it mixed directly into their low-
protein foods. The powder can also be utilized in special low-phenylalanine 
recipes for pastries, breads, puddings, ice creams, and sauces. Realization on 
the part of the mother or others responsible for feeding a child, of how the 
diet can be varied and still meet the child's needs will lead to easier control 
and success with the diet. Quite naturally it is easier to introduce this new 
diet to a small baby than to an older child. 
In the early months of life, the baby's low-phenylalanine formula may be 
supplemented with a small quantity of milk plus extra vitamins and iron. As the 
baby grows older, all varieties of fruits and certain low protein vegetables, 
such as carrots, beets, string beans, squash, turnips, tomatoes, etc., are added. 
These low protein foods continue to form the basis of the food supplements and 
later, depending on the amount of phenylalanine allowed and the child's preference, 
two or three small servings of cereal, potato or cookies may be added to the daily 
menu. Small doses of supplementary vitamins and iron may be given as an extra 
precautionary measure, although with the recent inclusion of vitamin C, the 
Lofenalac formula is probably adequate in these factors. Sample diets for 
infants and young children are given in the table on the following page. 
Age lUld Formula Breakfast 
weight 
15 measures 
2 months Lofenalac@ 
(10 lbs.) 2 oz. milk 
26 oz. water 
22 measures ~ cup chopped 
8 months Lofenalac@ peaches 
(18 lbs.) 2 oz. milk 8 oz. formula 
25 oz. water 
26 measures ~ cup dried rice 
2 yrs. Lofenalac@ cereal* with 
(26lbs.) 1 oz. milk 3 oz. formula 
20 oz. water with sugar 
~cup. orange 
secnons 
6 oz. formula 
27 measures ~ cup dried rice 
4 yrs. Lofenalac@ cereal* with 
(36lbs.) 25 oz. water 2-3 oz. formula 
1 small orlUlge 
8 oz. formula 
1 measure= 1 tablespoon 
Midmorn- Dinner Midafter- Supper Bedtime 
ing noon 
Five or six 5-6 ounce feeding· of formula 
~ cup chopped * cup chopped 8 oz. 
carrots pears formula 
8 oz. formuia 8 oz. formula 
?h cup cooked 2 animal 3 tbsp. of 
carrots cookies green beans 
2* tbsp. mashed 6 oz. 3 pear halves 
potato made formullt 6 oz. formula 
with formula 
and 1 tsp. 
butter 
% cup apple sauce 
6 oz. formula 
wedges ~ cus cabbage 3 animal ?h banana Synthetic 
of apple an carrot salad cookies ~ cup tapioca fruit 
with vinegar and 4oz. pudding made llavored 
oil dressing formula !V~th pineapple drink 
~ cup homemade Jwce 
vegetable soup 8 oz. formula. 
1 peach half 
8 oz. formula 




From these sample menus, a handy rule of thumb should be noticed. 
Children about 1 year of age need approximately 1 measure (tablespoon) of 
Lofenalac® per pound of body weight each day. For younger infants the need 
is proportionately greater, and for older children, it is proportionately less. 
One of the means of helping parents is to provide them the food lists and 
special recipes that have been devised for low-phenylalanine diets. The food 
lists give the equivalent amounts of food that provide 15 mg. of phenylalanine, 
called one "equivalent" according to one plan that has been devised. By substit-
uting equivalents of various foods, the parents can easily vary the diet and 
still keep within the prescribed amount of phenylalanine. 
It should be noted that every child will not take to a low-phenylalanine 
diet without any difficulty. Depending on this personality, the older the 
child is, the more he will miss his previous diet, and the more resistance he 
will put up to the new diet. But experience has shown that the difficulties that 
were encountered with older mixtures have not been a problem. Within a week, 
even two and three year olds have been drinking the Lofenalac~ and liking it--
and without the use of special flavoring or sweetening. 
Any physician who starts and supervised this diet must be prepared to spend 
extra time with the family. Public health nurses, nutritionists, and social 
workers are valuable assistants in this field. Conscientious, continued follow-
up guidance and counseling are essential for long-range success of the program. 
The length of time that a child should be kept on the diet to obtain optimal 
and permanent benefit has been the subject of much interesting discussion. In the 
natural course of the disease, it seems that deterioration does not continue much 
beyond three years of age and this has been quoted as the age after which the 
special diet may not be necessary. The issue has been confused by the fact that 
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a few PKU children who were not treated until after three years have shown good 
improvement, At the present time, scattered experiences are indicating that 
children over three years are maintaining their I.Q. 's off the diet, However, 
since it seems to be true that the adverse personality effects of phenylketonuria 
as well as mental deficiency respond somewhat to the low-phenylalanine diet, it 
will be interesting to see whether this will be a factor in the duration of treat-
ment. Some believe that discontinuance of the diet should occur in adolescence 
rather than at three to four years of age. In fact, recent evidence suggests that 
female phenylketonurics who are desirous of pregnancy may have to be on a low-
phenylalanine diet during the entire pregnancy. The repor.ts of retarded children 
being born to PKU mothers suggests that elevated maternal serum phenylalanine 
may cause foetal damage in utero. On the other hand, there have been reports of 
women with PKU producing normal children. It will take a few more years of research 
and study to be certain of the long-term effects of diet treatment on both mentality 
and personality. 
It should be emphasized that the child must be under a doctor's care at all 
times while on the diet to assure the maintenance of prescribed levels of phenyla-
lanine both for maximal benefit to the child's mentality and to prevent dietary 
deficiency. 
It has been shown that the mental deficiency of phenylketonuria (PKU) can 
be prevented or favorable modified if a speical low-phenylalanine diet is started 
early in life. Those concerned with child health are faced with the challenge of 
finding these children during infancy. 
As of November 1966, thirty-seven of the fifty states in the United States 
had passed laws and these laws were in effect pertaining to phenylketonuria. 
These thirty-seven states are Alabama, Alaska, California, Colorado, Connecticut, 
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Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, 
Louisiana, Maine, Maryland, Massachusett, Michigan, Minnesota, Missouri, 
Montana, New Hampshire, New Jersey, New Mexico, New York, Ohio, Oklahoma, 
Oregon, Pennsylvania, Rhode Island, South Carolina, Texas, Utah, Virginia, 
West Virginia, and Wisconsin. These laws all require that all infants be 
tested for phenylketonuria. 
On the whole, it has been may observation, that the majority of the 
American people seem to be extremely apathetic in regard to phenylketonuria. 
In fact, during the eighteen week period of my research in this area, I have 
run across a very few people who even know what PKU is and/or have ever heard 
of it, This is an extremely grave situation when we stop to realize that 
these apathetic and "ignorant'' (on this subject) people are future parents, if 
not parents all ready! 
If this situation weren't sad enough, it seems that some of our "influential 
and prominent'' elected legislators have gone on record as being opposed to any 
type of legislation that would insure that each child be tested for PKU--a step 
that, in my opinion, could be nothing but beneficial not only for the children 
affected but for all Americans. (For more in depth study on this aspect see 
Saturday Review, June 3, 1967, p. 56+). 
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